JOHN MENDLEIN Insider Trading $EDIT Editas Medicine, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN MENDLEIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN MENDLEIN. JOHN MENDLEIN is Director in ACLARA BIOSCIENCES INC ($ACLA) and CEO & Executive Chariman in aTYR PHARMA INC ($LIFE) and CEO and Director in aTYR PHARMA INC ($LIFE) and CEO and Executive Chairman in aTYR PHARMA INC ($LIFE) and Director in aTYR PHARMA INC ($LIFE) and See Remarks in aTYR PHARMA INC ($LIFE) and Director in FATE THERAPEUTICS INC ($FATE) and Director in Editas Medicine, Inc. ($EDIT).
JOHN MENDLEIN in Editas Medicine, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN MENDLEIN: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 19 2017
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN MENDLEIN in Editas Medicine, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACLA, LIFE, EDIT, FATE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 19 2017 | EDIT | Editas Medicine, I ... | MENDLEIN JOHN | Director | Option Exercise | A | 15.63 | 11,538 | 180,339 | 11,538 | |
| Feb 04 2016 | EDIT | Editas Medicine, I ... | MENDLEIN JOHN | Director | Option Exercise | A | 16.00 | 96,153 | 1,538,448 | 96,153 |
Page: 1